Posted by Michael Wonder on 06 Jun 2017
Proposal to list a range of orthopaedic implants and associated products supplied by Johnson & Johnson
6 June 2017 - PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated products supplied by Johnson & Johnson in Part III of Section H of the Pharmaceutical Schedule from 1 August 2017.
In summary, this proposal, subject to consultation and approval, would result in schedule listings for around 13,300 orthopaedic implants and associated products, which are already supplied to DHB Hospitals, being supplied by Johnson & Johnson under the terms and conditions of their current suture agreement.
